✦ LIBER ✦

An updated catalog of prostate cancer predictive tools

✍ Scribed by Shahrokh F. Shariat; Pierre I. Karakiewicz; Claus G. Roehrborn; Michael W. Kattan

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 447 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23908

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Updating risk prediction tools: A case s

Updating risk prediction tools: A case study in prostate cancer

✍ Donna P. Ankerst; Tim Koniarski; Yuanyuan Liang; Robin J. Leach; Ziding Feng; Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

## Abstract Online risk prediction tools for common cancers are now easily accessible and widely used by patients and doctors for informed decision‐making concerning screening and diagnosis. A practical problem is as cancer research moves forward and new biomarkers and risk factors are discovered,

Analysis of prognostic factors in dissem

Analysis of prognostic factors in disseminated prostatic cancer. An update

✍ Peter F. A. Mulders; Gerhard A. Dijkman; Pilar Fernandez Del Moral; Ad G. M. The 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

The European randomized study of screeni

The European randomized study of screening for prostate cancer : An update

✍ Bo Standaert; Louis Denis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Background: A consensus meeting on screening and global strategy for prostate carcinoma, held in antwerp in 1994, determined the willingness among european cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial. this trial was to

The surgery of prostate cancer: An updat

The surgery of prostate cancer: An update of contemporary radical prostatectomy and brachytherapy series

✍ Jason S. Krumholtz; Gerald L. Andriole 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

Prostate cancer is the most commonly diagnosed malignancy among men in the United States. Radical prostatectomy has been the gold standard for treating clinically localized prostate cancer. Its morbidity and disease-control capabilities have been well studied. At 10 years after surgery, 50% to 70% o

Biomolecular markers of outcome predicti

Biomolecular markers of outcome prediction in prostate cancer

✍ Alessia Lopergolo; Nadia Zaffaroni 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Critical assessment of tools to predict

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men

✍ Felix K.-H. Chun; Alexander Haese; Sascha A. Ahyai; Jochen Walz; Nazareno Suardi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract ## BACKGROUND. Overtreatment of prostate cancer (PCa) is a concern, especially in patients who might qualify for the diagnosis of insignificant prostate cancer (IPCa). The ability to identify IPCa prior to definitive therapy was tested. ## METHODS. In a cohort of 1132 men a nomogram